Publications

5808 Results

SWOG 0012: a phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus G-CSF as neoadjuvant therapy for inflammatory and locally advanced breast cancer [PMID21220618; PMC3024910]

Authors
G Ellis;W Barlow;J Gralow;G Hortobagyi;C Russell;M Royce;E Perez;D Lew;R Livingston
Journal / Conference
Journal of Clinical Oncology 29(8):1014-1021;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0012

A phase II trial of complete resection for stage IV melanoma: results of Southwest Oncology Group (SWOG) clinical trial S9430

Authors
J Sosman;J Moon;J Tuthill;J Warneke;J Vetto;BG Redman;PY Liu;J Unger;L Flaherty;V Sondak
Journal / Conference
Cancer 117:4740-4746;
Year
2011
Research Committee(s)
Melanoma
PMID
PMID21455999
PMC
PMC3129414
Study Number(s)
SWOG-9430

Phase II evaluation of early oral estramustine, oral etoposide and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group (SWOG) S0032 [PMID21334731]

Authors
DC Smith;CM Tangen;G Harrer;PJ Van Veldhuizen;G Harrer;A Golshayan;G Mills;N Vogelzang;IM Thompson;MHA Hussain
Journal / Conference
Urology 77(5):1172-1176; Epub 2011 Feb 21;
Year
2011
Research Committee(s)
Genitourinary
Study Number(s)
S0032

Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study [PMID21502546; PMC3107759]

Authors
T Dorff;T Flaig;C Tangen;MHA Hussain;G Swanson;DP Wood, Jr;W Sakr;N Dawson;N Haas;ED Crawford;NJ Vogelzang;IM Thompson;LM Glode
Journal / Conference
Journal of Clinical Oncology 29(15)2040-2045;
Year
2011
Research Committee(s)
Genitourinary
Study Number(s)
S9921

Comparison of platinum based chemotherapy in patients older and younger than 70 years of age: an analysis of Southwest Oncology Group trials 9308 and 9509 [PMID21107287; PMC3075557]

Authors
E Blanchard;J Moon;P Hesketh;K Kelly;A Wozniak;J Crowley;D Gandara
Journal / Conference
Journal of Thoracic Oncology, 6(1):115-120;
Year
2011
Research Committee(s)
Lung
Study Number(s)
SWOG-9308, SWOG-9509

Southwest Oncology Group Study S0413: a phase II trial of GW572016 (lapatinib) as first line therapy in patients with advanced or metastatic gastric cancer [PMID21415234;PMC3221514]

Authors
S Iqbal;B Goldman;C Fenoglio-Preiser;HJ Lenz;W Zhang;KD Dannenberg;S Shibata;C Blanke
Journal / Conference
Annals of Oncology, 22(12):2610-2615;
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
S0413

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202

Authors
S Iqbal;C Rankin;HJ Lenz;PJ Gold;S Ahmad;A El-Khoueiry;M Messino;R Holcombe;CD Blanke
Journal / Conference
Cancer Chemotherapy and Pharmacology 68(6):1595-602; 2011 May 20 [Epub ahead of print];
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
S0202

Outcomes among black patients with stage II/III colon cancer receiving adjuvant chemotherapy: an accent group analysis [PMID21997132; PMC3196480]

Authors
G Yothers;D Sargent;N Wolmark;R Goldberg;M O'Connell;J Benedetti;L Saltz;J Dignam;A Blackstock
Journal / Conference
Journal of the National Cancer Institute 103(20):1498-1506; JAMA
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Serum estrogen levels and prostate cancer risk in the Prostate Cancer Prevention Trial: a nested case-control study. PMID 21667068; PMC3139891

Authors
S Yao;C Till;A Kristal;P Goodman;A Hsing;C Tangen;E Platz;F Stanczyk;J Reichardt;L Tang;M Neuhouser;R Santella;W Figg;D Price;H Parnes;SM Lippman;IM Thompson;C Ambrosone;A Hoque
Journal / Conference
Cancer Cause and Control 22(8):1121-1131;
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Excision repair cross-complementation group 1 (ERCC1) gene expression (GE) is associated with outcome in stage II-III esophageal adenocarcinoma (EA) patients treated with preoperative platinum-based chemoradiation (CRT) in a phase II cooperative study (SWOG 0356)

Authors
P Bohanes;B Goldman;J Benedetti;C Blanke;L Leichman;S Iqbal;C Thomas;C Corless;P Gold;H Lenz
Journal / Conference
Journal of Clinical Oncology 29:(suppl 4: abstr 2); ASCO GI Cancers Symposium 2011, oral presentation
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
S0356